Artículos de revistas sobre el tema "Systemic Lupus Erythematosus, Health-related Quality of Life, Patient-Reported Outcomes"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Systemic Lupus Erythematosus, Health-related Quality of Life, Patient-Reported Outcomes".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Schmeding, A. y M. Schneider. "Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus". Best Practice & Research Clinical Rheumatology 27, n.º 3 (junio de 2013): 363–75. http://dx.doi.org/10.1016/j.berh.2013.07.009.
Texto completoMagro-Checa, C., L. J. J. Beaart-van de Voorde, H. A. M. Middelkoop, M. L. Dane, N. J. van der Wee, M. A. van Buchem, T. W. J. Huizinga y G. M. Steup-Beekman. "Outcomes of neuropsychiatric events in systemic lupus erythematosus based on clinical phenotypes; prospective data from the Leiden NP SLE cohort". Lupus 26, n.º 5 (abril de 2017): 543–51. http://dx.doi.org/10.1177/0961203316689145.
Texto completoRodríguez-Rivera, Diana V., Yerania Rodríguez-Navedo, Mariely Nieves-Plaza y Luis M. Vilá. "Patient-reported outcome measures in a population of medically indigent patients with systemic lupus erythematosus in Puerto Rico". SAGE Open Medicine 4 (1 de enero de 2016): 205031211667092. http://dx.doi.org/10.1177/2050312116670927.
Texto completoSaletra, A., J. Meenakshi, K. Fronczyk, Z. Czuszyńska, M. Sierakowska, M. Szmyrka y M. Olesińska. "AB1490 THE POLISH VALIDATION OF A DISEASE SPECIFIC PATIENT REPORTED OUTCOME MEASURE OF SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 1849. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5335.
Texto completoBALITSKY, AMARIS K., VALENTINA PEEVA, JIANDONG SU, ELAHEH AGHDASSI, ERIC YEO, DAFNA D. GLADMAN, MURRAY B. UROWITZ y PAUL R. FORTIN. "Thrombovascular Events Affect Quality of Life in Patients with Systemic Lupus Erythematosus". Journal of Rheumatology 38, n.º 6 (1 de marzo de 2011): 1017–19. http://dx.doi.org/10.3899/jrheum.101054.
Texto completoMoiseev, S., P. Novikov y N. Bulanov. "Systemic lupus erythematosus: epidemiology, outcomes and burden". Clinical pharmacology and therapy 31, n.º 4 (13 de noviembre de 2021): 13–22. http://dx.doi.org/10.32756/0869-5490-2021-4-13-22.
Texto completoElefante, Elena, Chiara Tani, Chiara Stagnaro, Francesco Ferro, Alice Parma, Linda Carli, Viola Signorini et al. "Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus". RMD Open 6, n.º 1 (febrero de 2020): e001133. http://dx.doi.org/10.1136/rmdopen-2019-001133.
Texto completoElkaraly, N. E., S. I. Nasef, A. S. Omar, A. M. Fouad, J. Meenakshi y A. E. Mohamed. "AB1238 THE ARABIC LUPUSPRO: CROSS-CULTURAL VALIDATION OF A DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME TOOL FOR QUALITY OF LIFE IN LUPUS PATIENTS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1909.1–1910. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4042.
Texto completoParodis, Ioannis y Paul Studenic. "Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver’s Seat in Their Disease Monitoring?" Journal of Clinical Medicine 11, n.º 2 (11 de enero de 2022): 340. http://dx.doi.org/10.3390/jcm11020340.
Texto completoFangtham, M., S. Kasturi, R. R. Bannuru, J. L. Nash y C. Wang. "Non-pharmacologic therapies for systemic lupus erythematosus". Lupus 28, n.º 6 (8 de abril de 2019): 703–12. http://dx.doi.org/10.1177/0961203319841435.
Texto completoStrand, Vibeke, Lee S. Simon, Alexa Simon Meara y Zahi Touma. "Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review". Lupus Science & Medicine 7, n.º 1 (junio de 2020): e000373. http://dx.doi.org/10.1136/lupus-2019-000373.
Texto completoJolly, M., N. Annapureddy, L. Arnaud y H. Devilliers. "Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial". Lupus 28, n.º 14 (1 de noviembre de 2019): 1628–39. http://dx.doi.org/10.1177/0961203319886065.
Texto completoEraslan, E., R. Bilici Salman, H. Satiş, A. Avanoglu Guler, H. Karadeniz, H. Küçük, S. Haznedaroglu, M. A. Ozturk, A. Tufan y B. Goker. "AB0300 LUPUS DISEASE ACTIVITY CORRELATES WITH QUALITY OF LIFE BUT NOT WITH HEALTH LITERACY STATUS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 1176.2–1176. http://dx.doi.org/10.1136/annrheumdis-2021-eular.581.
Texto completoUgarte-Gil, Manuel Francisco, Claudia Mendoza-Pinto, Cristina Reátegui-Sokolova, Guillermo J. Pons-Estel, Ronald F. van Vollenhoven, George Bertsias, Graciela S. Alarcon y Bernardo A. Pons-Estel. "Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review". Lupus Science & Medicine 8, n.º 1 (septiembre de 2021): e000542. http://dx.doi.org/10.1136/lupus-2021-000542.
Texto completoGomez, A., J. Lindblom, V. Qiu, A. Cederlund, A. Borg, S. Emamikia, Y. Enman, J. Lampa y I. Parodis. "POS0101 ADVERSE HEALTH-RELATED QUALITY OF LIFE OUTCOME DESPITE ADEQUATE CLINICAL RESPONSE TO TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 260.2–261. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1472.
Texto completoDoi, Hiroshi, Koichiro Ohmura, Yuya Tabuchi, Motomu Hashimoto, Yudai Takase, Ryuta Inaba, Tomohiro Kozuki et al. "Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life". Lupus 30, n.º 7 (28 de marzo de 2021): 1108–15. http://dx.doi.org/10.1177/09612033211005026.
Texto completoUgarte-Gil, Manuel Francisco, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Mariela Medina, Claudia Elera-Fitzcarrald, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza, Risto Alfredo Perich-Campos y Graciela S. Alarcón. "A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort". Lupus Science & Medicine 10, n.º 1 (febrero de 2023): e000874. http://dx.doi.org/10.1136/lupus-2022-000874.
Texto completoCorzo Garcia, P., I. Carrión Barberà, I. Garcia-Duitama, A. Agustí Claramunt, S. Marsico, J. Monfort y T. C. Salman Monte. "AB0491 MUSCULOSKELETAL INVOLVEMENT, CONFIRMED BY CONTRAST ENHANCED MRI, CONTRIBUTES TO A WORSE HEALTH-RELATED QUALITY OF LIFE IN SLE PATIENTS". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 1372.2–1372. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1923.
Texto completoSkoglund, Oliver, Tomas Walhelm, Ingrid Thyberg, Per Eriksson y Christopher Sjöwall. "Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes". Journal of Clinical Medicine 11, n.º 18 (8 de septiembre de 2022): 5300. http://dx.doi.org/10.3390/jcm11185300.
Texto completoPinto, B., M. Jolly, A. Dhooria, S. Grover, J. M. Raj, H. Devilliers y A. Sharma. "Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus". Lupus 28, n.º 13 (21 de octubre de 2019): 1534–40. http://dx.doi.org/10.1177/0961203319880340.
Texto completoKernder, Anna, Christina Düsing, Jutta Richter, Ralph Brinks, Rebecca Fischer-Betz, Borgi Winkler-Rohlfing, Martin Aringer, Matthias Schneider y Gamal Chehab. "Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients – Analysis of the German LuLa study". Lupus 30, n.º 12 (octubre de 2021): 1931–37. http://dx.doi.org/10.1177/09612033211045063.
Texto completoCintrón, D., J. M. Alanis, N. Álvarez-Villalobos, R. Rodríguez-Gutiérrez y L. M. Vilá. "A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus". Lupus 29, n.º 3 (7 de febrero de 2020): 303–10. http://dx.doi.org/10.1177/0961203320904145.
Texto completoAntony, A., R. K. Kandane-Rathnayake, T. Ko, D. Boulos, A. Y. Hoi, M. Jolly y E. F. Morand. "Validation of the Lupus Impact Tracker in an Australian patient cohort". Lupus 26, n.º 1 (20 de agosto de 2016): 98–105. http://dx.doi.org/10.1177/0961203316664593.
Texto completoMartínez-Rosales, Elena, Sergio Sola-Rodríguez, José Antonio Vargas-Hitos, Blanca Gavilán-Carrera, Antonio Rosales-Castillo, Alba Hernández-Martínez, Enrique G. Artero, José Mario Sabio y Alberto Soriano-Maldonado. "Heart Rate Variability in Women with Systemic Lupus Erythematosus: Association with Health-Related Parameters and Effects of Aerobic Exercise". International Journal of Environmental Research and Public Health 17, n.º 24 (18 de diciembre de 2020): 9501. http://dx.doi.org/10.3390/ijerph17249501.
Texto completoGrabich, Shannon, Eileen Farrelly, Robert Ortmann, Michael Pollack y Sandra Sze-jung Wu. "Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016–2018". Lupus Science & Medicine 9, n.º 1 (mayo de 2022): e000640. http://dx.doi.org/10.1136/lupus-2021-000640.
Texto completoAGGARWAL, ROHIT, CAITLYN T. WILKE, A. SIMON PICKARD, VIKRANT VATS, RACHEL MIKOLAITIS, LEWIS FOGG, JOEL A. BLOCK y MEENAKSHI JOLLY. "Psychometric Properties of the EuroQol-5D and Short Form-6D in Patients with Systemic Lupus Erythematosus". Journal of Rheumatology 36, n.º 6 (15 de abril de 2009): 1209–16. http://dx.doi.org/10.3899/jrheum.081022.
Texto completoGomez, A., F. H. Butrus, P. Johansson, E. Åkerström, S. Soukka, S. Emamikia, Y. Enman, S. Pettersson y I. Parodis. "FRI0168 ASSOCIATION OF OVERWEIGHT/OBESITY WITH IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 668–69. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4016.
Texto completoHanly, J. G., M. B. Urowitz, D. Jackson, S. C. Bae, C. Gordon, D. J. Wallace, A. Clarke et al. "SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus". Annals of the Rheumatic Diseases 70, n.º 6 (21 de febrero de 2011): 961–67. http://dx.doi.org/10.1136/ard.2010.138792.
Texto completoElefante, E., C. Tani, V. Signorini, C. Stagnaro, D. Zucchi, F. Trentin, L. Carli, F. Ferro y M. Mosca. "POS0753 PROSPECTIVE EVALUATION OF HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN A MONOCENTRIC COHORT OF PATIENTS WITH LONGSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 662. http://dx.doi.org/10.1136/annrheumdis-2022-eular.2708.
Texto completoArdhaoui, M., M. Brahem, S. Arfa, B. Ben Rejeb, M. Hassayoun, R. Sarraj, H. Hachfi, O. Berriche y Y. Mohamed. "AB0526 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS USING SF-36 SCALE". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 1391.1–1391. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3629.
Texto completoCollacott, H., A. Phillips-Beyer, N. Krucien, K. Marsh y B. Flamion. "POS0086-PARE PATIENT PREFERENCES FOR SYSTEMIC LUPUS ERYTHEMATOSUS TREATMENTS: A DISCRETE CHOICE EXPERIMENT". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 264.2–264. http://dx.doi.org/10.1136/annrheumdis-2022-eular.830.
Texto completoFouad, Ahmed M., Sally F. Elotla, Nourhan E. Elkaraly y Aly E. Mohamed. "Impact of COVID-19 Pandemic on Patients with Rheumatic and Musculoskeletal Diseases: Disruptions in Care and Self-Reported Outcomes". Journal of Patient Experience 9 (enero de 2022): 237437352211026. http://dx.doi.org/10.1177/23743735221102678.
Texto completoWilliams-Hall, Rebecca, Pamela Berry, Nicola Williamson, Melissa Barclay, Anna Roberts, Adam Gater, Chloe Tolley et al. "Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)". Lupus Science & Medicine 9, n.º 1 (agosto de 2022): e000712. http://dx.doi.org/10.1136/lupus-2022-000712.
Texto completoFredi, M., C. Orlandi, M. Salvi, C. Bazzani, C. Nalli, L. Andreoli y F. Franceschini. "POS0117 DISEASE ACTIVITY AND CLINICAL REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS: COMPARISON BETWEEN PATIENT AND PHYSICIAN PERSPECTIVES BY MEANS OF PATIENT REPORTED OUTCOMES (PROs)". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 283.2–284. http://dx.doi.org/10.1136/annrheumdis-2022-eular.2761.
Texto completoReutemann, E., R. Brinks, J. G. Richter, R. Fischer-Betz, B. Winkler-Rohlfing, M. Aringer, M. Schneider y G. Chehab. "POS0362 FACTORS ASSOCIATED WITH CHANGES IN COPING BEHAVIOUR IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS - A LONGITUDINAL STUDY OF THE LuLa COHORT". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 434.3–434. http://dx.doi.org/10.1136/annrheumdis-2022-eular.918.
Texto completoMucke, Johanna, Oliver Kuss, Ralph Brinks, Sabine Schanze y Matthias Schneider. "LUPUS-BEST—treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trial". Lupus Science & Medicine 8, n.º 1 (julio de 2021): e000516. http://dx.doi.org/10.1136/lupus-2021-000516.
Texto completoWilliams, E. M., C. L. Dismuke, T. D. Faith, B. L. Smalls, E. Brown, J. C. Oates y L. E. Egede. "Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the Peer Approaches to Lupus Self-management (PALS) pilot study". Lupus 28, n.º 8 (5 de junio de 2019): 937–44. http://dx.doi.org/10.1177/0961203319851559.
Texto completoBlomjous, B., G. Gajadin, I. Bultink, A. Voskuyl, L. Falzon, J. Hoving y M. Ter Wee. "FRI0156 WORK PARTICIPATION IN PATIENTS WITH SYSTEMATIC LUPUS ERYTHEMATOSUS: A SYSTEMATIC REVIEW". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 662.1–662. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3555.
Texto completoAringer, M., L. Arnaud, C. Peschken, R. Furie, E. F. Morand, C. Seo, E. Rapsomaniki et al. "POS0731 ASSOCIATION OF PATIENT-REPORTED OUTCOMES WITH TYPE I INTERFERON GENE SIGNATURE FROM THE INTERNATIONAL SYSTEMIC LUPUS ERYTHEMATOSUS PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 648–49. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1181.
Texto completoGomez, Alvaro, Sofia Soukka, Petter Johansson, Emil Åkerström, Sharzad Emamikia, Yvonne Enman, Katerina Chatzidionysiou y Ioannis Parodis. "Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus". Journal of Clinical Medicine 9, n.º 6 (10 de junio de 2020): 1813. http://dx.doi.org/10.3390/jcm9061813.
Texto completoJesus, D., A. Matos, C. Henriques, A. Doria y L. Inês. "POS0119 SLE-DAS REMISSION AND LOW DISEASE ACTIVITY STATES ARE ASSOCIATED WITH IMPROVED HEALTH-RELATED QUALITY OF LIFE AND FATIGUE: POST-HOC ANALYSIS OF THE BLISS-52 AND BLISS-76 PHASE III TRIALS." Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 284.2–285. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3634.
Texto completoUgarte-Gil, M. F., R. V. Gamboa Cárdenas, C. Reategui Sokolova, V. Pimentel-Quiroz, M. Medina Chinchon, C. Elera-Fitzcarrald, Z. Rodriguez Bellido, C. Pastor Asurza, R. Perich Campos y G. S. Alarcon. "POS0730 A BETTER SELF-EFFICACY IS PREDICTIVE OF BETTER HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS. DATA FROM A LATIN AMERICAN MESTIZO COHORT". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 647.2–647. http://dx.doi.org/10.1136/annrheumdis-2022-eular.727.
Texto completoTouma, Z., B. Hoskin, C. Atkinson, D. Bell, J. Pike, J. H. Lofland, P. Berry, C. Karyekar y K. Costenbader. "AB1170 THE IMPACT OF HIGH DISEASE ACTIVITY AS MEASURED BY SLEDAI AND DRUG BURDEN-ON HEALTHCARE UTILIZATION, QUALITY OF LIFE AND WORK PRODUCTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1875.2–1876. http://dx.doi.org/10.1136/annrheumdis-2020-eular.5872.
Texto completoMannix, S., A. Beyer, V. Strand, L. Hanrahan, C. Abél, B. Flamion y A. Hareendran. "AB1249 ASSESSMENT OF FATIGUE IN ADULTS WITH MODERATE-TO-SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A QUALITATIVE STUDY TO EXPLORE WHAT PATIENTS FEEL SHOULD BE MEASURED IN CLINICAL TRIALS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1916. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3849.
Texto completoGomez, A., I. Parodis y C. Sjowall. "AB0549 OBESITY AND TOBACCO SMOKING ARE INDEPENDENTLY ASSOCIATED WITH POOR PATIENT-REPORTED OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM A SWEDISH TERTIARY REFERRAL CENTRE". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 1402.1–1402. http://dx.doi.org/10.1136/annrheumdis-2022-eular.4335.
Texto completoKhattab, Nada M., Maggie Abbassi, Hala A Raafat y Samar Farid. "A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt". Lupus 31, n.º 4 (7 de marzo de 2022): 505–16. http://dx.doi.org/10.1177/09612033221083270.
Texto completoAzizoddin, D. R., R. Olmstead, C. Cost, M. Jolly, J. Ayeroff, G. Racaza, L. A. Sumner, S. Ormseth, M. Weisman y P. M. Nicassio. "A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus". Lupus 26, n.º 9 (6 de enero de 2017): 967–74. http://dx.doi.org/10.1177/0961203316686706.
Texto completoBerry, P., K. Burrows, R. Hall, A. Gater, H. Bradley, A. Ward, C. Tolley, P. Delong y E. C. Hsia. "AB1332-HPR ASSESSING THE PATIENT EXPERIENCE OF LUPUS NEPHRITIS: DEVELOPMENT OF A CONCEPTUAL MODEL AND REVIEW OF EXISTING PATIENT-REPORTED OUTCOME (PRO) MEASURES". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1954.1–1955. http://dx.doi.org/10.1136/annrheumdis-2020-eular.5634.
Texto completoGeorge, James N. "TTP: long-term outcomes following recovery". Hematology 2018, n.º 1 (30 de noviembre de 2018): 548–52. http://dx.doi.org/10.1182/asheducation-2018.1.548.
Texto completoAzizoddin, D. R., N. Gandhi, S. Weinberg, M. Sengupta, P. M. Nicassio y M. Jolly. "Fatigue in systemic lupus: the role of disease activity and its correlates". Lupus 28, n.º 2 (22 de diciembre de 2018): 163–73. http://dx.doi.org/10.1177/0961203318817826.
Texto completo